Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.660
-0.020 (-1.19%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cerus Revenue
Cerus had revenue of $46.02M in the quarter ending September 30, 2024, with 15.70% growth. This brings the company's revenue in the last twelve months to $176.23M, up 14.71% year-over-year. In the year 2023, Cerus had annual revenue of $156.37M, down -3.51%.
Revenue (ttm)
$176.23M
Revenue Growth
+14.71%
P/S Ratio
1.73
Revenue / Employee
$276,655
Employees
637
Market Cap
308.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 156.37M | -5.68M | -3.51% |
Dec 31, 2022 | 162.05M | 31.19M | 23.83% |
Dec 31, 2021 | 130.86M | 38.94M | 42.36% |
Dec 31, 2020 | 91.92M | 17.27M | 23.14% |
Dec 31, 2019 | 74.65M | 13.74M | 22.56% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Spok Holdings | 137.71M |
Sanara MedTech | 78.06M |
Delcath Systems | 22.64M |
Nyxoah | 5.67M |
Lexicon Pharmaceuticals | 5.23M |
Absci | 4.21M |
Immutep | 2.56M |
Lyell Immunopharma | 63.00K |
CERS News
- 8 days ago - Cerus Corporation to Participate in Upcoming Investor Conferences - Business Wire
- 21 days ago - Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Cerus Corporation Announces Third Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024 - Business Wire
- 4 weeks ago - Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting - Business Wire
- 5 weeks ago - Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe - Business Wire
- 3 months ago - Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range - Business Wire